BDX Q2 2022 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q2 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.8B-3.2% YoY

Gross Profit

$2.1B44.5% margin

Operating Income

$564M11.9% margin

Net Income

$454M9.6% margin

EPS (Diluted)

$1.50

QoQ Revenue Growth

+0.7%

Cash Flow

Operating Cash Flow

$444M

Free Cash Flow

$217M

Stock-Based Comp.

$57M

Balance Sheet

Total Assets

$54.8B

Total Liabilities

$30.3B

Stockholders' Equity

$24.5B

Cash & Equivalents

$3.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.8B	$4.9B	-3.2%
Gross Profit	$2.1B	$2.2B	-5.9%
Operating Income	$564M	$434M	+30.0%
Net Income	$454M	$299M	+51.8%

Revenue Segments

Medical

$2.4B48%

Life Sciences

$1.5B30%

Interventional

$1.1B22%

Geographic Segments

UNITED STATES

$2.8B56%

Non-US

$2.2B44%